LAS VEGAS -- Children and teens with Crohn's disease who received early tumor necrosis antagonist (anti-TNF) treatment had a lower risk of developing perianal fistulizing complications (PFCs) than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results